Medicine · shortage history
Buprenorphine
Notified short 3 times on record since 2025. Every entry links to its source; grouping is by medicine name (dm+d coding will refine it).
Most recently declared short 15 Jan 2026. We record when a shortage is declared, not when stock returns — the source doesn't publish that, so this is the shortage history, not live availability. Check with your pharmacy for today's stock.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 15 Jan 2026 | Medicine Supply Notification: Buprenorphine/naloxone (Suboxone® ) 2mg/500microgram and 8mg/2mg sublingual tablets | Supply notification | Tier 2 | MSN/2026/002 |
| 19 Jun 2025 | Medicine Supply Notification: Buprenorphine (Relevtec®) 35micrograms/hour, 52.5micrograms/hour, 70micrograms/hour transdermal patches Buprenorphine (Bupeaze®) 52.5micrograms/hour transdermal patches | Supply notification | Tier 2 | MSN/2025/038 |
| 07 May 2025 | Medicine Supply Notification: Buprenorphine (Reletrans® ) 5micrograms/hour and 15micrograms/hour transdermal patches | Supply notification | Tier 2 | MSN/2025/030 |
An update that shares a reference counts as one episode, so this list can show more rows than the count above. Grouped by the medicine named in each notice's title. Until dm+d coding lands, brand and generic names (and combination products) may sit under separate or first-ingredient entries — see methodology. Not an official NHS or DHSC service.